Skip to content
Screener

Astrana Health ASTH Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$956.0MBeat by $25.6M
EPS$0.01Miss by $0.46
Revenue estimate$930.5M
EPS estimate$0.47

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$1.0B
EPS estimate$0.42

Financials

Q3 2025

Income statement

See full
Revenue$956.0M+99.7%
Gross profit$97.2M+32.2%
Operating income$19.2M-32.4%
Net income$373.0K-97.7%
EPS (diluted)$0.01-97.0%

Balance sheet

See full
Cash & equivalents$462.2M+32.8%
Total debt$1.1B+128%
Total equity$775.5M+10.1%
Total assets$2.2B+74.0%

Cash flow

See full
Operating cash flow$10.0M-70.7%
CapEx$2.6M+11.2%
Free cash flow$7.4M-76.6%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.31B-52.6%
Enterprise value$1.93B-33.0%
P/S0.5×-1.2×

Profitability

See full
Gross margin10.3%-4.8pp
Operating margin2.1%-3.0pp

Returns & leverage

See full
Debt / equity1.4×+0.7×
Current ratio1.4×-0.5×

Segments

By product

See full
Health Care Patient Service$40.1M+114%
Health Care Other$30.8M+41.4%
Management Service$15.2M+454%

FAQ

When did Astrana Health report Q3 2025 earnings?
Astrana Health (ASTH) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Astrana Health's Q3 2025 revenue and EPS?
Astrana Health reported revenue of $956.0M and eps of $0.01 for Q3 2025.
Did Astrana Health beat estimates in Q3 2025?
Revenue beat the consensus estimate of $930.5M by $25.6M. EPS missed the consensus estimate of $0.47 by $0.46.
How did Astrana Health's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 99.7% from $478.7M a year earlier and eps declined 97.0% from $0.33.
Where can I find Astrana Health's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-107754) and the 10-Q periodic report (0001193125-25-274359) directly on SEC EDGAR. The filing index links above go to sec.gov.